Our study confirms that MBC is morphologically and biologically distinct from FBC by the higher frequency of NST carcinomas and ER-positive luminal A and B carcinomas, as well as the rarity of HER2 enriched and TNBC [4,5,13,14]. This evidence concerns the gene ERBB2 and carcinoma.